We provide you with 20 years of free, institutional-grade data for GBS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GBS. Explore the full financial landscape of GBS stock.
| Reported Date | CIK | Ticker | Type |
|---|
GBS Inc(NASDAQ:GBS) 
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormon...
Website: https://gbs.inc/
Founded: 1995
Full Time Employees: 7 (May 2021)
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
The information provided in this report about GBS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.